Newsroom | ALK
Are you a journalist?

Get to know ALK

If you have any queries please feel free to contact Media Relations at ALK headquarters or one of our global offices.

The press releases in this press room contains information that is of general news value for the press, and available for journalists or media with a view to journalistic assessment and preparation before publication.

News

  • Post date
    02/19/2025
    Annual report 2024: ALK delivers 15% sales growth with profits up 65%
  • Post date
    02/19/2025
    Annual General Meeting in ALK-Abelló A/S on 13 March 2025
  • Post date
    02/12/2025
    Invitation to the presentation of ALK’s annual report 2024 on Wednesday, 19 February 2025
  • Post date
    01/30/2025
    ALK’s house dust mite tablet (ACARIZAX®) now recommended by NICE for use in the UK health system
  • Post date
    12/20/2024
    ALK – Financial calendar for the 2025 financial year
  • Post date
    12/18/2024
    Positive results advance peanut tablet to phase II development
  • Post date
    12/12/2024
    ACARIZAX® approved in Europe for treatment of young children
  • Post date
    11/27/2024
    ALK’s pivotal phase 3 trial in children published in reputable scientific journal
  • Post date
    11/14/2024
    Nine-month interim report (Q3) 2024 (unaudited)

Media Relations

Maiken Riise Andersen
Communications Director & Head of Media Relations 
Phone: +45 50541434
Email: MRIDK@alk.net

Journalists are always welcome to contact ALK’s Media Relations team.
Peter Halling, President & CEO
Claus Steensen Sølje, CFO
Søren Niegel, EVP Commercial Operations
Henriette Mersebach, EVP Research and Development
Lika Thiesen, EVP Global People & Organisation
Christian G. Houghton, EVP Product Supply
Jan Engel, SVP Global Quality
Jacob Glenting, SVP Global Strategy & Corporate Development
Image
ALK Lab 1
Production facilities, Hørsholm
Image
ALK Lab 2
Production facilities, Hørsholm
Image
ALK Lab 3
Production facilities, Hørsholm
Image
ALK HQ
ALK HQ, Hørsholm
Last updated: 30.01.2025